NEW USE FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
Application 1200/DELNP/2004 published 2006-12-08, filed 2004-05-05
The present invention relates to the use of cannabinoid receptor agonists for the inhibition of transient lower esophageal sphincter relaxations. A further aspect of the invention is directed to the use of cannabinoid receptor agonists for the treatment of gastroesophageal reflux disease, as well as for the treatment of regurgitation such as regurgitation in infants, lung disease, chronic laryngitis and asthma.
Applicant
1)ASTRAZENECA AB
:S-151 85 SÃDERTÃLJE SWEDEN
Inventor
1)ANDERS LEHMANN
International Info
Classification: A61F13/15
Publication Number: WO 03/043619 A1
Application Date: 2002-11-20
Priority Information
01103936.1 Sweden 2001-11-23